NCT05138653View on ClinicalTrials.gov

A Single and Multiple Ascending Dose Trial of CVL-354 in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

73

Participants

Timeline

Start Date

October 18, 2021

Primary Completion Date

January 23, 2023

Study Completion Date

January 23, 2023

Conditions
Healthy Participants
Interventions
DRUG

CVL-354

Oral solution/suspension

DRUG

Placebo

Placebo matched to CVL-354

DRUG

CVL-354

Capsule

Trial Locations (1)

75247

Labcorp Drug Development, Dallas

Sponsors
All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

Cerevel Therapeutics, LLC

INDUSTRY

NCT05138653 - A Single and Multiple Ascending Dose Trial of CVL-354 in Healthy Participants | Biotech Hunter | Biotech Hunter